FDA Drug recall D-1535-2014
Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement
- FDA Drug
- Class I
- terminated
- Published 2014-08-20
On 2014-08-20 the FDA classified a Class I recall of Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement by Sung Soo Kim, citing marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1535-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2014-04-15 |
| Published | 2014-08-20 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Sung Soo Kim |
| Distribution | US |
Product
Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement. Manufactured for & Distributed by Nanowellbeing Health, Inc., 14747 Artesia Blvd, #5V, La Mirada, CA 90638. UPC: 7 99475 35350 5.
Reason
Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.
Identifiers
| upc | 799475353505 |
|---|---|
| code_info | Lot #: L1P1-6100 (expiry 6/25/2016) and L1P2-6000 (expiry 9/16/2016). |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1535-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.